Relapsed neuroblastomas show frequent RAS-MAPK pathway mutationsThomas F. Eleveld, John M. Maris, Derek A. Oldridge et al.|Nature Genetics|2015Cited by 563
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH studyJoëlle Vermeulen, Jo Vandesompele, Katrien Swerts et al.|The Lancet Oncology|2009Cited by 196
Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutationsDerek A. Oldridge, Jan J. Molenaar, Thomas F. Eleveld et al.|Cancer Research|2015Cited by 0